Your browser version is outdated. We recommend that you update your browser to the latest version.

DeNovX is ...

an innovative pharmaceutical company that provides platform products that improve crystallization outcomes for pharmaceuticals and proteins.

  • Our pharmaceutical technology division is focused on the commercialization of products to accelerate pharmaceutical development while creating new intellectual property (IP) for commercially relevant products. These innovative approaches to improving crystallization also have application in structural biology by improving crystallization outcomes. For more information about our crystallization tools, please click here.

  • Our pharmaceutical products division is advancing the development of a clinically de-risked drug for the treatment of ulcerative colitis. For more information on our ulcerative colitis drug, please click here.